Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genomic Research Center, |
RCV000625793 | SCV000746345 | uncertain significance | Cerebellar ataxia, intellectual disability, and dysequilibrium syndrome 4 | 2020-05-03 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001868158 | SCV002255423 | likely benign | not provided | 2024-01-13 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002531927 | SCV003567630 | uncertain significance | Inborn genetic diseases | 2022-04-25 | criteria provided, single submitter | clinical testing | The c.2333G>A (p.R778Q) alteration is located in exon 25 (coding exon 25) of the ATP8A2 gene. This alteration results from a G to A substitution at nucleotide position 2333, causing the arginine (R) at amino acid position 778 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |